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Alkamides are one of the most important constituents of lipophilic extracts of Echinacea angustifolia roots. These compounds play an important role in the 
versatile pharmacological actions of this plant. The present study aimed to compare the concentrations of isomeric dodeca-2E,4E,8Z,10E/Z-tetraenoic acid 
isobutylamides (DTAI) in brain and periepididymal fat tissues and blood plasma of rats. Thirty, 60, 240 and 720 min after the oral administration of                 
E. angustifolia root extract, tissue and plasma concentrations were determined by reversed-phase HPLC with ESI-MS/MS detection. The calculated terminal t½ 
of the mixture of DTAI was 8.28 h, which indicates a relatively slow elimination. In the 0.5–4 h period the brain/plasma and fat/plasma concentration ratios 
were continuously above 3 and 18, respectively, followed by equilibrium at 12 h. Our results indicate substantial accumulation of alkamides in lipid-rich 
tissues, which presumably contributes to a maintained pharmacological action. 
 




Echinacea species are the most widely used immunomodulatory 
plants in the treatment of common cold. Pharmacologically active 
constituents of Echinacea species are alkamides, alkylketones, 
caffeic acid derivatives and polysaccharides [1, 2]. Isomeric 
dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides (DTAI) 
(Figure 1) are the main alkamides in the roots of E. purpurea, 
E. angustifolia and E. pallida and in the herbs of E. purpurea and 




Figure 1: Chemical structures of dodeca-2E,4E,8E,10E/Z-tetraenoic acid 
isobutylamides. 
 
Alkamides may play an important role in the medicinal benefits of 
Echinacea extracts. Alkamides of E. purpurea stimulated, dose-
dependently, the phagocytic activity of alveolar macrophages in rats 
[4]. Two Echinacea-derived alkamides suppressed the ability of 
activated Jurkat T cells to produce IL-2 in a dose-dependent manner 
[5]. The alkamide mixture purified from E. angustifolia decreased 
significantly the lipopolysaccharide stimulated NF-κB level, TNF-α 
and NO production in macrophages in vitro [6]. Polyunsaturated 
alkamides isolated from Achillea species and E. angustifolia roots 
were shown to possess inhibitory activity in in vitro cyclooxygenase 
and 5-lipoxygenase assays [7]. These data suggest that alkamides 
may have not only immunostimulatory but also anti-inflammatory 
activity. DTAI have been found to inhibit both cyclooxygenase and 
5-lipoxygenase at micromolar concentrations [8]. Extract of E. 
angustifolia decreased anxiety in the elevated plus-maze, social 
interaction and social avoidance tests in rodents [9]. The extract of 
the plant can significantly regulate excitatory, but not inhibitory, 
synaptic transmission in the hippocampus, and this action might be 
involved in its anxiolytic effects observed in behaviour tests [10]. 
Certain alkamides act as cannabinomimetics at both the cannabinoid 
CB1 and CB2 receptors [11-13]. Alkamides of E. angustifolia 
extract may contribute to decreased mild anxiety symptoms since 
CB1 receptors are implicated in anxiety [14]. Data concerning the 
absorption, metabolism, bioavailability, and bioactivity of natural 
products and their metabolites are primarily important to link results 
from in vitro assays and clinical studies. Woelkart et al. evaluated 
the pharmacokinetics of DTAI in rat plasma, as well as in liver and 
brain tissues [15]. Goey et al. have described a validated HPLC-
MS/MS procedure for quantitative analysis of DTAI in human 
plasma [16]. Although lipid soluble substances may be deposited in 
fat tissues which may fundamentally influence the pharmacokinetic 
behaviour of such compounds, no data are available concerning the 
concentrations of DTAI in depot fat. 
 
In this research, we studied the concentration changes of DTAI      
in brain and periepididymal adipose tissues of rats using an    
HPLC-MS/MS method, and compared them with those in plasma of 
the animals. Terminal t½ of DTAI was also calculated. 
 
Oral treatment of rats with 50 mg/kg E. angustifolia root extract 
was performed in order to obtain data concerning the 
pharmacokinetics of the active constituents both in plasma and 
lipid-rich brain and fat tissues. DTAI concentration was maximal in 
all samples collected 30 min after treatment indicating fast 
absorption and distribution (Figure 2). The plasma curve of DTAI 
revealed a typical two-compartment pharmacokinetic behaviour 
with a distribution completed within 1 hour, followed by an 
elimination phase. The calculated half-life (t½) of DTAI was 8.27 h 
and the elimination constant (ke) was 0.084 1/h. 
 
The highest concentration of DTAI was detected in the 
periepididymal fat. The level in the periepididymal fat tissue was 
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18–24 times higher than in the plasma in the period 0.5–4 h and 
reached equilibrium by 12 h (Table 1). High concentrations       
were found in the brain too but the tissue/plasma ratios were lower 




Figure 2: DTAI concentrations in the plasma (■), brain (○) and fat tissue (●) 
samples of rats treated with 50 mg/kg Echinacea extract (N: 6). 
 
Table 1: Concentration ratios of DTAI. 
 
Time (h) Brain/plasma ratio Fat/plasma ratio 
0.5 7.10 30.23 
1 3.03 20.61 
4 4.60 35.22 
12 0.51 0.96 
 
DTAI concentrations in plasma, brain and fat tissue samples 
obtained from rats were determined by means of HPLC-MS/MS 
0.5–12 h after oral treatment with Echinacea extract (Figure 3). 
Since the main purpose of our study was the comparison of 
concentrations in relevant tissues (brain and fat) with those in 
plasma the timing of the sample collection is not optimal for a 
complete pharmacokinetic analysis. However, the calculated 
terminal t½ of the analyte was 8.27 h, which indicates a substantially 
slower elimination than reported previously after the administration 
of the pure compounds [15]. Therefore, it is suggested that some 
directly ineffective constituents may exert profound action on the 
pharmacokinetic profile and therefore the overall effect of the 
Echinacea preparation [17]. 
 
Figure 3: MRM chromatogram of periepididymal adipose tissue 4 hours after 
Echinacea extract administration (solid line) and the 0.8 ng/20 μL concentration 
calibration standard (dotted line). 
 
Highly lipid-soluble substances tend to accumulate in fat tissue and 
this may basically influence the disposition of the drug. However, 
none of the previously published studies were extended to the 
determination of DTAI in adipose tissue. This is the first report 
presenting direct comparison of DTAI concentrations in plasma, 
brain and fat. Our data indicate that DTAI reaches considerably 
high concentration, presumably maximal in the body in adipose 
tissue. DTAI deposited in the fat may contribute to a sustained brain 
concentration. If such redistribution is operative in humans it may 
implicate that the relative fat weight may exert a profound action on 





Chemicals and reagents: DTAI was isolated from E. angustifolia 
by Hohmann et al. [12] and its identity and purity (95%) was 
investigated by 1H NMR (500 MHz, CDCl3). Benzanilide (purity 
99.9%) and methylcellulose were purchased from Sigma-Aldrich 
Co. (St. Louis, MO, USA), acetonitrile (LiChrosolv HPLC grade) 
from Merck KGaA (Darmstadt, Germany), and formic acid and 
methanol (analytical grade) from Reanal Zrt. (Budapest, Hungary). 
Millipore Direct-Q UV3 (Millipore, Bedford, MA, USA) clarifier 
was used to produce purified water for HPLC-MS measurements. 
The E. angustifolia root extract (extraction: ethanol 85%, v/v; ratio 
of herbal drug - native extract: 6.5–8:1; excipient: maltodextrin 
30%; marker: echinacoside 4%) was purchased from Euromed SA 
(Millet del Valles, Spain; Batch No. 419061). 
 
Calibration standards and quality control samples: Standard stock 
solution was prepared by dissolving solid DTAI in water-
acetonitrile (6:4) in a concentration of 1 μg/20 μL. Working 
standard solutions were prepared by serial dilutions using water-
acetonitrile (6:4) from the stock solution to final concentrations that 
covered the concentration range of the assay. The benzanilide 
internal standard (IS) stock solution, 4.12 ng/20 μL, was prepared 
using water-acetonitrile (6:4). Its concentration was 1 ng/20 μL in 
the calibration standards and in the samples. Quality control 
samples (QC) were prepared using the procedure of sample 
preparation at the concentrations of 0.023 ng/20 µL (LC) and 0.920 
ng/20 µL (HC). The IS concentration was 1 ng/20 μL. 
 
Animals and treatment: Animals were treated in accordance with 
the European Communities Council Directives (86/609/ECC) and 
the Hungarian Act for the Protection of Animals in Research 
(XXVIII. section 243/1998). All experiments involving animal 
subjects were carried out with the approval of the Hungarian Ethical 
Committee for Animal Research (registration number: IV./01758-
2/2008). Male Wistar rats of 200–240 g body weight (Toxi-Coop, 
Budapest, Hungary) were housed in temperature (20–23°C), 
humidity (40–60%) and light (12 h of light, 12 h of dark) regulated 
rooms, with water and standard rodent food (Bioplan, Isaszeg, 
Hungary) intake available ad libitum. Animals were fasted for 16 h 
before oral treatment with 50 mg/kg E. angustifolia extract 
suspended in 0.25% methylcellulose in a dosing volume of 
5 mL/kg. Six animals were randomized into each group. 
 
Sample collection and preparation: After 30, 60, 240 and 720 min 
rats were anesthetized with isoflurane inhalation and blood samples 
were collected by cardiac puncture. Blood coagulation was 
prevented and plasma was prepared by centrifugation (4000 RPM, 
10 min, 4°C). Plasma samples of 200 µL were extracted 2 times 
with 1200 µL methanol and 15 µL IS solution was added. The 
sample was homogenised by vortexing for 90 sec. After both 
extractions the samples were centrifuged (6200 RPM, 15 min, 4°C) 
and the collected supernatants were evaporated under nitrogen at 
room temperature. Whole brains were removed and periepididymal 
adipose tissues from both sides were collected and wet weights 
were recorded. Tissues were homogenized in a double volume of 
methanol, vortexed for 90 sec and centrifuged (6200 RPM, 15 min, 
4°C). Fifteen µL IS solution was added to 500 µL supernatant and 
evaporated as mentioned before. Samples were dissolved in 200 μL 
water-acetonitrile (6:4) in an ultrasonic bath and then filtered using 
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a 0.45 μm pore size syringe filter into chromatographic sample 
bottles. Pharmacokinetic parameters were calculated by means of 
PKSolver in noncompartmental analyses [18]. 
 
HPLC-MS/MS conditions: LC analyses were performed using a 
Shimadzu HPLC system (Shimadzu, Tokyo, Japan), equipped with 
2 LC-20AD pumps, CBM-20A controller, SPD-20A UV-Vis 
detector, SIL-20A autosampler, DGU-20A3 degasser and CTO-
20AC column thermostat, coupled to an API 2000 triple quadrupole 
mass spectrometer, equipped with an electrospray (ESI) interface 
(AB SCIEX, Framingham, MA, USA). Chromatographic separation 
was achieved with a Phenomenex Kinetex XB-C18 column (2.1 × 
50 mm; 2.6 µm) and a C18 guard column (both supplied by Gen-
Lab Kft., Budapest, Hungary). Eluent A was 0.1% formic acid in 
acetonitrile and eluent B was 0.1% formic acid in water at a flow 
rate of 500 µL/min. The elution gradient started with 40% of eluent 
A, keeping isocratic conditions for 0.5 min. Then, eluent A 
increased to 90% in 1.0 min and was held for 1.0 min. Finally, 
initial conditions were reached again in 1.2 min, with a re-
equilibration time of 1.7 min in order to restore the column. The 
sample injection volume was set at 20 μL. The ion source 
temperature was 325°C. Measurements were carried out in positive 
ionization mode and the quantification was accomplished by using 
multiple reaction monitoring (MRM) with transitions of m/z 
248→152 for DTAI and m/z 198→105 for benzanilide. Data 
acquisition and evaluation were performed using Analyst 1.5.1 
software. 
 
Method validation: The applied HPLC-MS method, described 
above, was used and validated by Woelkart et al. [15] to quantitate 
DTAI in rat plasma and other tissues, except periepididymal fat. In 
this assay, validation was carried out only for periepididymal fat 
samples. The R2 value for the standard curve was 0.9992 and the 
linear range was determined between 0.021–1.050 ng/20 μL. Limit 
of detection and limit of quantification were 0.0043 and 0.0214 
ng/20 μL, respectively. Relative standard deviations of the replicate 
measurements were 19.8% for LC and 0.87% for HC samples. 
Extraction recovery was 75% for LC and 58% for HC samples. 
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